← SynDRA
PIBOSEROD
SynDRA canonical compound SYN0004867 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR2B | HTR4 |
|---|
| Mechanism of action | serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HTR4 ANTAGONIST
- Serotonin 4 (5-HT4) receptor antagonist
- HTR2B ANTAGONIST
- serotonin receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD2
- DRD3
- HTR1A
- HTR1D
- HTR1E
- HTR2A
- AGTR1
- HDAC6
- HTR3A
- KCNH2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- SB-207266
- UNII-4UQ3S81B25
- SB 207266
- SB207256
- 4UQ3S81B25
- N-((1-butylpiperidin-4-yl)methyl)-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide
- N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- Piboserod [INN:BAN]
- Serotonin 5-HT4 Receptor Antagonists
- SB207266(Piboserod)
- AC1L42OO
- GTPL225
- SCHEMBL467339
- CHEMBL356359
- BDBM85026
- DTXSID60165129
- piboserodum
- RefChem:174124
- DTXCID8087620
- MFCD00923681
- Piboserod [INN]
- Piboserod?
- PIBOSEROD [MI]
- PIBOSEROD [WHO-DD]
- orb1305814
- SCHEMBL30234609
- KVCSJPATKXABRQ-UHFFFAOYSA-N
- EX-A1189
- PDSP1_001702
- PDSP2_001685
- AKOS015909931
- FD10684
- SB-207266-A
- NCGC00250378-01
- AC-36094
- AS-82492
- BP166459
- HY-15574
Look up PIBOSEROD in the interactive SynDRA portal →